Well, I am down pretty hard on this.. but It's not gonna keep me down forever.
The due diligence that myself and others here did on Mymetics is very valuable.
If the formulation would have been done correctly, we could all very well have been sitting at .25 cents by now singing a different song right now.
There was no way I or anyone could have predicted that we would have a set-back on the testing done with Sanofi. We should have took caution when October 21st came and passed and we had no word from MYMX. Unfortunately it went against us.
The guy that sits on the Board of Directors, has 141 million shares last I read..
and he invested what.. almost 50 million Euros in this company and owns 49% or maybe even more now of the company...
So while the share price is depressed right now, and tax loss season is upon us.. I believe there is an opportunity at hand to pick up low hanging shares.
But you must be prepared to hold them for a long time.. meaning months to a year..
Otc Markets is showing a market value of Friday's Share price at 6.6 million.
Market Value $6,682,668 a/o Nov 17, 2017 (.0225 Price)
Fridays closing price: .0225
Today the closing price is .019
which is 16% less than Fridays closing price..
So tomorrow when OTCMARKETS.com is updated it will reflect a market value 16 % less that 6.6 mil
So that is going to bring the market value down to about 5.6 million
So right now the market is valuing Mymetics at 5.6 million dollars based on perception.
This is ridiculous considering the 50 million Euros that have been loaned to Mymetics are tied to the patents, clinical trial data, and company's intellectual and physical property.
The Note holder who sits on the Board of Directors, believes this is worth more than 50 million Euros based on the Patents and clinical trial data.
While impossible to know for sure yet, I tend to agree with him. I believe these are grossly undervalued pick-ups, but that the market perception will take a while to improve again after this debacle.
The CEO knows the shareholders are pissed.. We just don't know if he will throw us a bone between here and the next Sanofi update.
I plan on sticking around to see what happens no matter how long it takes.
